CCM
WGSWW

CAAS Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

CAAS Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,500
Closed -$148K – 1311
2021
Q1 		$148K Buy
+28,500
New +$158K ﹤0.01% 1064

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

CAAS Capital Management's WGSWW Position: Q2 2021 in Review

CAAS Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q2 2021, closing a stake of 28,500 shares — an estimated $148K sold.

CAAS Capital Management first reported a position in WGSWW in Q1 2021 and held it in 1 quarter. The position peaked at $148K in Q1 2021. 25 funds tracked by Wall St. Rank hold WGSWW as of Q2 2021.

  • CAAS Capital Management reported no remaining GeneDx Holdings Warrant position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 28,500 GeneDx Holdings Warrant shares in Q2 2021, an estimated $148K.
  • CAAS Capital Management first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 1 quarter.
  • CAAS Capital Management's GeneDx Holdings Warrant position peaked at $148K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.